Delayed ontogenesis of CYP1A2 in the human liver

被引:0
|
作者
Sonnier, M.
Cresteil, T.
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Delayed ontogenesis of CYP1A2 in the human liver
    Sonnier, M
    Cresteil, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (03): : 893 - 898
  • [2] EXPRESSION OF CYP1A1 AND CYP1A2 GENES IN HUMAN LIVER
    SCHWEIKL, H
    TAYLOR, JA
    KITAREEWAN, S
    LINKO, P
    NAGORNEY, D
    GOLDSTEIN, JA
    PHARMACOGENETICS, 1993, 3 (05): : 239 - 249
  • [3] Involvement of human liver CYP1A2 in the metabolism of propofol
    Oda, Y
    Hamaoka, N
    Hase, I
    Tanaka, K
    Asada, A
    ANESTHESIOLOGY, 1999, 91 (3A) : U244 - U244
  • [4] Pathway-targeted pharmacogenornics of CYP1A2 in human liver
    Klein, Kathrin
    Winter, Stefan
    Turpeinen, Miia
    Schwab, Matthias
    Zanger, Ulrich M.
    FRONTIERS IN PHARMACOLOGY, 2010, 1
  • [5] Pathway-targeted pharmacogenomics of CYP1A2 in human liver
    Klein, K.
    Winter, S.
    Turpeinen, M.
    Schwab, M.
    Zanger, U. M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 81 - 82
  • [6] Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype
    Jiang, Zhengwen
    Dragin, Nadine
    Jorge-Nebert, Lucia F.
    Martin, Martha V.
    Guengerich, F. Peter
    Aklillu, Eleni
    Ingelman-Sundberg, Magnus
    Hammons, George J.
    Lyn-Cook, Beverly D.
    Kadlubar, Fred F.
    Saldana, Shannon N.
    Sorter, Michael
    Vinks, Alexander A.
    Nassr, Nassr
    von Richter, Oliver
    Jin, Li
    Nebert, Daniel W.
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (05): : 359 - 367
  • [7] Selective inhibitory effects of mollugin on CYP1A2 in human liver microsomes
    Kim, Heeyeon
    Choi, Hyun Kyu
    Jeong, Tae Cheon
    Jahng, Yurngdong
    Kim, Dong Hyun
    Lee, Seung-Ho
    Lee, Sangkyu
    FOOD AND CHEMICAL TOXICOLOGY, 2013, 51 : 33 - 37
  • [8] Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes
    Paudel, Sanjita
    Jo, Hyoje
    Lee, Taeho
    Lee, Sangkyu
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (05) : 365 - 371
  • [9] Synergistic role of the human CYP1A2 promoter and dioxin response element in the induction of CYP1A2
    Raucy, Judy L.
    Kramer, Kyle
    Quattrochi, Linda C.
    DRUG METABOLISM REVIEWS, 2006, 38 : 114 - 114
  • [10] Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9
    Otake, Y
    Walle, T
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (02) : 103 - 105